Brought to you by 
Series D brings in $21mm for InfraReDx
09 Jan 2015
Executive Summary
InfraReDx Inc. (cardiovascular diagnostic imaging technologies) has raised $21mm through its Series D venture round. Current shareholder Sanderling Ventures led the financing and was joined by new institutional investors, including GMP Securities. The company will use the proceeds for the commercial launch of its LipiScan IVUS coronary imaging system, which recently gained US approval as a tool to identify and characterize plaque in the coronary arteries.
Deal Industry
- Medical Devices
-
Medical Devices
- Laser
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Diagnostic Imaging Equipment & Supplies
- Ultrasound
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series D brings in $21mm for InfraReDx
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice